Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic targeting of endoplasmic reticulum stress in acute graft-versus-host disease.
Haring E, Andrieux G, Uhl FM, Krausz M, Proietti M, Sauer B, Esser PR, Martin SF, Pfeifer D, Schmitt-Graeff A, Duyster J, Köhler N, Grimbacher B, Boerries M, Aumann K, Zeiser R, Apostolova P. Haring E, et al. Among authors: krausz m. Haematologica. 2022 Jul 1;107(7):1538-1554. doi: 10.3324/haematol.2021.278387. Haematologica. 2022. PMID: 34407601 Free PMC article.
Treatment of STAT3-deficient hyper-immunoglobulin E syndrome with monoclonal antibodies targeting allergic inflammation.
James AE, West L, Schloss K, Nataraj P, Urban A, Hirsch A, Krausz M, Kumar S, Raasch J, Risma K, Church JA, Grimbacher B, Bergerson JRE, Chong H, Freeman AF. James AE, et al. Among authors: krausz m. J Allergy Clin Immunol Pract. 2022 May;10(5):1367-1370.e1. doi: 10.1016/j.jaip.2022.01.011. Epub 2022 Jan 24. J Allergy Clin Immunol Pract. 2022. PMID: 35085810 No abstract available.
The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial.
Krausz M, Uhlmann A, Rump IC, Ihorst G, Goldacker S, Sogkas G, Posadas-Cantera S, Schmidt R, Feißt M, Alsina L, Dybedal I, Recher M, Warnatz K, Grimbacher B. Krausz M, et al. Contemp Clin Trials Commun. 2022 Sep 24;30:101008. doi: 10.1016/j.conctc.2022.101008. eCollection 2022 Dec. Contemp Clin Trials Commun. 2022. PMID: 36262801 Free PMC article.
Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
Krausz M, Mitsuiki N, Falcone V, Komp J, Posadas-Cantera S, Lorenz HM, Litzman J, Wolff D, Kanariou M, Heinkele A, Speckmann C, Häcker G, Hengel H, Gámez-Díaz L, Grimbacher B. Krausz M, et al. Front Immunol. 2022 Nov 2;13:1011646. doi: 10.3389/fimmu.2022.1011646. eCollection 2022. Front Immunol. 2022. PMID: 36405723 Free PMC article.
Corrigendum: Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?
Krausz M, Mitsuiki N, Falcone V, Komp J, Posadas-Cantera S, Lorenz HM, Litzman J, Wolff D, Kanariou M, Heinkele A, Speckmann C, Häcker G, Hengel H, Gámez-Díaz L, Grimbacher B. Krausz M, et al. Front Immunol. 2023 Jun 2;14:1226814. doi: 10.3389/fimmu.2023.1226814. eCollection 2023. Front Immunol. 2023. PMID: 37334381 Free PMC article.
Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4-Dependent Transendocytosis by Flow Cytometry.
Rojas-Restrepo J, Sindram E, Zenke S, Haberstroh H, Mitsuiki N, Gabrysch A, Huebscher K, Posadas-Cantera S, Krausz M, Kobbe R, Rohr JC, Grimbacher B, Gámez-Díaz L. Rojas-Restrepo J, et al. Among authors: krausz m. J Clin Immunol. 2023 Nov;43(8):2076-2089. doi: 10.1007/s10875-023-01582-9. Epub 2023 Sep 23. J Clin Immunol. 2023. PMID: 37740092 Free PMC article.
Correction to: Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4‑Dependent Transendocytosis by Flow Cytometry.
Rojas-Restrepo J, Sindram E, Zenke S, Haberstroh H, Mitsuiki N, Gabrysch A, Huebscher K, Posadas-Cantera S, Krausz M, Kobbe R, Rohr JC, Grimbacher B, Gamez-Diaz L. Rojas-Restrepo J, et al. Among authors: krausz m. J Clin Immunol. 2023 Nov;43(8):2090. doi: 10.1007/s10875-023-01596-3. J Clin Immunol. 2023. PMID: 37812314 Free PMC article. No abstract available.
Lipocalin-2 expression identifies an intestinal regulatory neutrophil population during acute graft-versus-host disease.
Czech M, Schneider S, Peltokangas N, El Khawanky N, Ghimire S, Andrieux G, Hülsdünker J, Krausz M, Proietti M, Braun LM, Rückert T, Langenbach M, Schmidt D, Martin I, Wenger V, de Vega E, Haring E, Pourjam M, Pfeifer D, Schmitt-Graeff A, Grimbacher B, Aumann K, Kircher B, Tilg H, Raffatellu M, Thiele Orberg E, Häcker G, Duyster J, Köhler N, Holler E, Nachbaur D, Boerries M, Gerner RR, Grün D, Zeiser R. Czech M, et al. Among authors: krausz m. Sci Transl Med. 2024 Feb 21;16(735):eadi1501. doi: 10.1126/scitranslmed.adi1501. Epub 2024 Feb 21. Sci Transl Med. 2024. PMID: 38381845
ADA2 is a lysosomal deoxyadenosine deaminase acting on DNA involved in regulating TLR9-mediated immune sensing of DNA.
Greiner-Tollersrud OK, Krausz M, Boehler V, Polyzou A, Seidl M, Spahiu A, Abdullah Z, Andryka-Cegielski K, Dominick FI, Huebscher K, Goschin A, Smulski CR, Trompouki E, Link R, Ebersbach H, Srinivas H, Marchant M, Sogkas G, Staab D, Vågbø C, Guerini D, Baasch S, Latz E, Hartmann G, Henneke P, Geiger R, Peng XP, Grimbacher B, Bartok E, Alseth I, Warncke M, Proietti M. Greiner-Tollersrud OK, et al. Among authors: krausz m. Cell Rep. 2024 Nov 26;43(11):114899. doi: 10.1016/j.celrep.2024.114899. Epub 2024 Oct 22. Cell Rep. 2024. PMID: 39441717 Free article.
384 results